![](/img/cover-not-exists.png)
BYL719, a new α-specific PI3K inhibitor: Single administration and in combination with conventional chemotherapy for the treatment of osteosarcoma
Gobin, Bérengère, Huin, Marc Baud', Lamoureux, François, Ory, Benjamin, Charrier, Céline, Lanel, Rachel, Battaglia, Séverine, Redini, Françoise, Lezot, Frédéric, Blanchard, Frédéric, Heymann, DominiquVolume:
136
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.29040
Date:
February, 2015
File:
PDF, 974 KB
english, 2015